EDS ECHO Event Series: Allergy and Immunology Complications
February 19, 2022
We are delighted to be hosting a dedicated event for allergy and immunology complications in the Ehlers-Danlos syndromes and hypermobility spectrum disorder. Join us as leading experts present the latest research, management, and scientific information.
This event is suitable for both healthcare professionals, and members of the EDS and HSD community, their families, and caregivers. 6 CME/CEU/CE Credits will be available for healthcare professionals to claim for sessions that are viewed LIVE.
This event will take place from 08:45 AM – 5:30 PM Eastern Time.
(Please use the converter world time buddy to find the correct times in your location)
The conference will take place online via Zoom Webinar. If you have questions please email firstname.lastname@example.org.
Lipedema is a chronic medical condition characterized by a symmetric buildup of adipose tissue (fat) in the legs and arms that occurs almost exclusively in women. It is a common but underrecognized disorder. Lipedema may cause pain, swelling, and easy bruising and be accompanied by an unusual texture within the fat that can feel like rice, peas, or walnuts beneath the surface of the skin.
At the Lipedema Foundation, we support collaborative research that addresses the basic biology, genetics, and epidemiology of lipedema with a mission to define, diagnose and develop treatments.
Please visit our website lipedema.org to learn more about the Lipedema Foundation.
39 Lewis Street,
+1-203-489-2989 | email@example.com
In support of improving patient care, this activity has been planned and implemented by the Ehlers-Danlos Society and Project ECHO. Project ECHO® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Designation Statement
Project ECHO® designates this live activity for a maximum of 6 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an eligible company.
None of the planners and presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Prof. Lara Bloom, Dr. Alan Hakim, Dr. Anne Maitland, Courtney Rabb, Stacey Simmonds, Sacha Aziz, Dr. Jonathan J. Lyons, Valerie Slee, Kate Robinson, Prof. Vik Khullar
The following planners / presenters listed below have disclosed that they have a relevant financial relationship with an ineligible company.
|Nature of Relationship||Name of Ineligible Company|
|Dr. Matthew Hamilton||Consultant||GSK, Allakos, Blueprint Medicine, Inveniai|
|Dr. Matthew Giannetti||Grants/Research Support||Blueprint medicines|
|Dr. Mariana Castells||Grants/Research Support||Blueprint medicines|
|Dr. Clair Francomano||Consultant
Scientific Advisory Board – Kyani International
All of the relevant financial relationships listed for this/these individual(s) have been mitigated.